Literature DB >> 7352427

An enzymatic approach to lipoprotein quantification.

B W Steele, D F Koehler, K Kuba, M M Azar.   

Abstract

Lipoprotein cholesterol levels were determined without ultracentrifugation by using modified enzymatic methods for cholesterol, high-density-lipoprotein (HDL) cholesterol, and triglyceride and the formula, low-density-lipoprotein (LDL) cholesterol = total cholesterol-HDL cholesterol-triglycerides/5. The methods for cholesterol and triglyceride determinations were standardized for accuracy and precision by the Center for Disease Control's Lipid Standardization Laboratory, which monitored this laboratory for 16 months. The lipoprotein cholesterol values obtained correlated well with lipoprotein cholesterol values determined at the Minnesota Lipid Research Clinic Laboratory using ultracentrifugation. LDL cholesterol determined at the Minneapolis Veterans Administration Hospital Laboratories (Y axis) produced a curve with an intercept of 9.38 mg/dl, a slope of .977, standard error of the estimate (Sy.x) of 8.8 mg/dl, and a correlation coefficient (r) of .983 (n = 32). HDL cholesterol was Y = 0.998 X + .89 mg/dl, Sy.x = 1.6 mg/dl (r = .984, n = 53), and very-low-density-lipoprotein (VLDL) cholesterol was Y = 1.010 X -1.32 mg/dl, Sy.x = 1.3 mg/dl (r = .996, n = 54).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7352427     DOI: 10.1093/ajcp/73.1.75

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  The EUROSTROKE cohorts: a short description and data analytical approach.

Authors:  M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; A Trichopoulou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; P C Elwood; J T Salonen; A Freire de Concalves; J Sivenius; A Di Carlo; Y Nikitin; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales.

Authors:  J W Yarnell; A M Fehily; J Milbank; A J Kubicki; R Eastham; T M Hayes
Journal:  J Epidemiol Community Health       Date:  1983-06       Impact factor: 3.710

4.  Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

5.  Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.

Authors:  J W Yarnell; P M Sweetnam; V Marks; J D Teale; C H Bolton
Journal:  Br Heart J       Date:  1994-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.